BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1590376)

  • 1. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes.
    Braun JE; Severson DL
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E477-85. PubMed ID: 1848407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptozotocin-induced diabetes enhances cardiac heparin-releasable lipoprotein lipase activity in spontaneously hypertensive rats.
    Shepherd G; Cam MC; Sambandam N; Abrahani MA; Rodrigues B
    Hypertension; 1998 Mar; 31(3):878-84. PubMed ID: 9495276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin.
    Sambandam N; Abrahani MA; St Pierre E; Al-Atar O; Cam MC; Rodrigues B
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1526-34. PubMed ID: 10364085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats.
    Rodrigues B; Severson DL
    Can J Physiol Pharmacol; 1993 Sep; 71(9):657-61. PubMed ID: 8313228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lipoprotein lipase activity in cardiac myocytes from control and diabetic rat hearts by plasma lipids.
    Rodrigues B; Braun JE; Spooner M; Severson DL
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1271-9. PubMed ID: 1493594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase activity is stimulated by insulin and dexamethasone in cardiomyocytes from diabetic rats.
    Ewart HS; Carroll R; Severson DL
    Can J Physiol Pharmacol; 1999 Aug; 77(8):571-8. PubMed ID: 10543720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial binding sites for lipoprotein lipase are not diminished in perfused hearts from diabetic rats.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1996 Nov; 74(11):1204-9. PubMed ID: 9028578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N; Lim F; Cam MC; Rodrigues B
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.
    Niu YG; Evans RD
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts.
    Severson DL; Lee M; Carroll R
    Mol Cell Biochem; 1988 Jan; 79(1):17-24. PubMed ID: 3374475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diabetes on acid and neutral triacylglycerol lipase and on lipoprotein lipase activities in isolated myocardial cells from rat heart.
    Ramírez I; Severson DL
    Biochem J; 1986 Aug; 238(1):233-8. PubMed ID: 3800935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.